PT
Menu
Search
Sections
Home
News
Analysis
Features
Comment & Opinion
Projects
Data Insights
Sectors
Clinical Trials
Drug Manufacturers
Therapy Area
Cardiovascular
Central Nervous System
Immunology
Infectious Disease
Oncology
Respiratory
Pricing and Market Access
Themes
Artificial Intelligence
Corporate Governance
Cloud
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Events
Reports
Premium Insights
Excellence Awards
Innovation Rankings
Magazine
Newsletters
GlobalData
About us
Advertise With Us
Contact Us
Our Marketing Solutions
GlobalData Reports
Visit GlobalData
From Our Partners
Transforming MedTech and Pharma using Software as a Medical Device (SaMD)
Accelerating Biopharmaceutical Innovation
Precision medicine and digital health innovation for disease diagnosis, care and treatment
Enabling process intensification in biopharma manufacturing
The next chapter of clinical trial services
Putting quality first in the pharma supply chain
Enabling better biopharmaceutical manufacturing
Pharmaceutical Grade Silicone Manufacturer
Maximising molecule potential
News
Analysis
Sections
Features
Comment & Opinion
Projects
Data Insights
Latest
BIO-Europe 2023: Pharma balances on shaky financial and legislative footing
FT Summit: AI and regulatory changes at the forefront of industry’s mind
Childproof packaging: How things are changing for consumer drugs
Sectors
Sections
Clinical Trials
Drug Manufacturers
Therapy Area
Pricing and Market Access
Latest
Xphozah wins orphan drug designation for paediatric hyperphosphatemia
Certa plans pivotal scleroderma trial after Phase II data readout
UK MHRA extends licence for Vertex’s children’s cystic fibrosis drugs
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Latest
Certa plans pivotal scleroderma trial after Phase II data readout
Astellas to take over Propella Therapeutics for $175m
Signal: Pfizer cuts 500 UK jobs in restructuring after posting Q3 loss
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Signal: Pfizer cuts 500 UK jobs in restructuring after posting Q3 loss
Signal: Wegovy cuts cardiovascular risk by 20% for heart disease patients
AstraZeneca posts 16% drop in Q3 2023 profit after tax
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Latest
A new era for pMDI propellants
Evaluating the top five sterilisation techniques for parenteral packaging
Analytical testing: Ten questions that accelerate drug development
Events
Reports
Premium Insights
Newsletters
PT
All articles by laura jenner
laura jenner
View more
Most Popular
Japan approves Daiichi Sankyo’s Covid-19 booster vaccine
FDA grants orphan drug status for Arcturus’ cystic fibrosis therapy
Signal: British biopharma applies for BLA for T-cell cancer therapy
